Physician profile
Corey E Mayo
NPI 1578742110
$6,604.73
in general payments reported to CMS, 2019-2025
23 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $460 · 2021: $904 · 2022: $571 · 2023: $540 · 2024: $1,695 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,544 · Travel and Lodging: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.77 |
| Travel and Lodging | $956.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,107.72 | 2020-2025 | Mako, Inspace, Mistral-Air |
| Zimmer Biomet Holdings, INC. | $1,066.18 | 2019-2024 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Pavmed INC. | $1,028.42 | 2021-2022 | |
| Trice Medical, INC. | $442.59 | 2019-2020 | |
| Horizon Therapeutics Plc | $168.32 | 2020-2022 | |
| Acera Surgical, INC. | $163.61 | 2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $124.36 | 2020-2025 | Iovera, Zilretta, Exparel |
| Orthalign INC | $111.18 | 2021 | |
| Arcuro Medical INC | $59.91 | 2024 | Superball |
| Vertex Pharmaceuticals Incorporated | $41.13 | 2024-2025 | |
| Organogenesis INC. | $39.82 | 2025 | Puraply Wound Matrix |
| Dynasplint Systems INC. | $37.37 | 2024 | Dynasplint |
| Collegium Pharmaceutical, INC. | $30.07 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.40 | 2023 | |
| Exactech, INC. | $22.62 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| P Bar Medical LLC | $21.29 | 2025 | |
| Bioventus LLC | $20.80 | 2025 | Exogen Ultrasound Bone Healing System |
| Davol INC. | $17.79 | 2024 | |
| Smith+Nephew, INC. | $17.46 | 2021 | |
| Pylant Medical | $17.34 | 2022 | |
| Pacira Therapeutics, INC. | $14.70 | 2019 | |
| Nevro Corp. | $14.47 | 2020 | |
| Fidia Pharma USA INC. | $14.18 | 2025 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Mayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.